A venture capital firm founded in 2019 and headquartered in Europe invests in healthtech startups in Pre-Seed to Seed stages across Europe as well as in the U.S., Canada, Israel, and Australia. Typical check size ranges from €200k-1.5M EUR, and the firm can lead rounds, co-invest, or follow.
The firm invests in healthcare companies that involves data information, technology, hardware, software, AI, and medtech that includes a strong data or computing component. The firm will not look at traditional medical devices such as surgical devices that does not have data components or traditional biotech such as therapeutics and drug development. The firm has broad indications and will look at different needs across the entire healthcare system such as need-based solutions for providers, better operations on the backend, direct solutions for patients, clinical trial needs, payer and insurance company solutions, and medical education platforms.
The firm often takes a board or observer seat though not required.
If you are interested in more information about this investor and other investors tracked by LSN, please email salescore@lifesciencenation.com.
Next Phase Newsletter 
Leave a comment